Stephens Inc. AR Purchases Shares of 85,222 Enovis Co. (NYSE:ENOV)

Stephens Inc. AR acquired a new position in Enovis Co. (NYSE:ENOV) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 85,222 shares of the company’s stock, valued at approximately $3,740,000. Stephens Inc. AR owned approximately 0.15% of Enovis at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Entropy Technologies LP increased its stake in Enovis by 8.9% in the 4th quarter. Entropy Technologies LP now owns 7,305 shares of the company’s stock worth $321,000 after buying an additional 598 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Enovis in the fourth quarter worth about $253,000. Leisure Capital Management purchased a new stake in shares of Enovis during the fourth quarter worth about $984,000. DAVENPORT & Co LLC raised its stake in Enovis by 6.0% during the 4th quarter. DAVENPORT & Co LLC now owns 2,782,341 shares of the company’s stock valued at $121,181,000 after purchasing an additional 157,216 shares during the period. Finally, Hantz Financial Services Inc. lifted its holdings in Enovis by 10.3% in the 4th quarter. Hantz Financial Services Inc. now owns 247,469 shares of the company’s stock worth $10,859,000 after purchasing an additional 23,073 shares in the last quarter. 98.45% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 price objective on shares of Enovis in a report on Thursday, November 7th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Enovis presently has an average rating of “Moderate Buy” and a consensus price target of $65.86.

Enovis Stock Performance

Shares of NYSE:ENOV opened at $44.45 on Tuesday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27. The firm has a market cap of $2.53 billion, a PE ratio of -20.30 and a beta of 1.94. The firm’s 50 day simple moving average is $45.82 and its 200-day simple moving average is $44.48. Enovis Co. has a one year low of $38.27 and a one year high of $65.03.

Enovis Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.